Avalide First-Line Indication Gets Unanimous Advisory Panel Endorsement
This article was originally published in The Pink Sheet Daily
Executive Summary
Some members of FDA’s Cardio-Renal Advisory Committee suggest indication could extend to moderately hypertensive patients, not just patients with severe disease.
You may also be interested in...
Bristol’s Avalide Approved For First-Line Treatment Of Hypertension
Therapy is indicated for use in patients “who are likely to need multiple drugs to achieve their blood pressure goals,” according to labeling.
IFRA Hosts Capitol Hill Scent Experience In Timeout From Policy Concerns
The International Fragrance Association North America took a break from its higher-stakes advocacy work Nov. 1 to give lawmakers and congressional staffers a "scent experience." Perfumers from six of the group's biggest members were on hand with "Scents of Home," joined by Monell Center researchers to educate attendees on the mechanics of scent and the important role it plays in people's lives.